Trilogy Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-574
| Closed | -$271K | – | 305 |
|
|
2023
Q4 | $271K | Sell |
574
-130
| -18% | -$61.3K | 0.02% | 220 |
|
|
2023
Q3 | $306K | Sell |
704
-86
| -11% | -$37.4K | 0.02% | 191 |
|
|
2023
Q2 | $376K | Buy |
790
+37
| +5% | +$17.6K | 0.02% | 195 |
|
|
2023
Q1 | $346K | Buy |
753
+142
| +23% | +$65.3K | 0.02% | 187 |
|
|
2022
Q4 | $313K | Buy |
611
+117
| +24% | +$60K | 0.02% | 193 |
|
|
2022
Q3 | $224K | Buy |
+494
| New | +$224K | 0.02% | 165 |
|
|
2019
Q1 | – | Sell |
-1,199
| Closed | -$315K | – | 133 |
|
|
2018
Q4 | $315K | Sell |
1,199
-253
| -17% | -$66.5K | 0.04% | 104 |
|
|
2018
Q3 | $398K | Sell |
1,452
-252
| -15% | -$69.1K | 0.05% | 98 |
|
|
2018
Q2 | $406K | Sell |
1,704
-246
| -13% | -$58.6K | 0.05% | 86 |
|
|
2018
Q1 | $428K | Buy |
+1,950
| New | +$428K | 0.06% | 85 |
|